vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and TechTarget, Inc. (TTGT). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $140.7M, roughly 1.7× TechTarget, Inc.). TechTarget, Inc. runs the higher net margin — -6.7% vs -35.0%, a 28.3% gap on every dollar of revenue. CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $11.6M).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
TechTarget, Inc. is an American company that offers data-driven marketing services to business-to-business technology vendors.
CCRN vs TTGT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $140.7M |
| Net Profit | $-82.9M | $-9.5M |
| Gross Margin | — | 63.8% |
| Operating Margin | -30.2% | -10.5% |
| Net Margin | -35.0% | -6.7% |
| Revenue YoY | -23.6% | — |
| Net Profit YoY | -2109.7% | — |
| EPS (diluted) | $-2.56 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $140.7M | ||
| Q3 25 | $250.1M | $122.3M | ||
| Q2 25 | $274.1M | $119.9M | ||
| Q1 25 | $293.4M | $103.9M | ||
| Q4 24 | $309.9M | — | ||
| Q3 24 | $315.1M | $62.9M | ||
| Q2 24 | $339.8M | — | ||
| Q1 24 | $379.2M | — |
| Q4 25 | $-82.9M | $-9.5M | ||
| Q3 25 | $-4.8M | $-76.8M | ||
| Q2 25 | $-6.7M | $-398.7M | ||
| Q1 25 | $-490.0K | $-523.4M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $2.6M | $-17.4M | ||
| Q2 24 | $-16.1M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | — | 63.8% | ||
| Q3 25 | 20.4% | 61.3% | ||
| Q2 25 | 20.4% | 57.3% | ||
| Q1 25 | 20.0% | 57.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | 62.1% | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | -10.5% | ||
| Q3 25 | -2.4% | -88.2% | ||
| Q2 25 | -2.1% | -342.1% | ||
| Q1 25 | -0.3% | -474.5% | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | 0.9% | -22.9% | ||
| Q2 24 | -5.7% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | -35.0% | -6.7% | ||
| Q3 25 | -1.9% | -62.8% | ||
| Q2 25 | -2.4% | -332.4% | ||
| Q1 25 | -0.2% | -503.8% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 0.8% | -27.7% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | $-2.56 | $-0.09 | ||
| Q3 25 | $-0.15 | $-1.07 | ||
| Q2 25 | $-0.20 | $-5.58 | ||
| Q1 25 | $-0.02 | $-7.32 | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.08 | $-0.42 | ||
| Q2 24 | $-0.47 | — | ||
| Q1 24 | $0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $40.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $594.6M |
| Total Assets | $449.0M | $937.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $40.6M | ||
| Q3 25 | $99.1M | $46.3M | ||
| Q2 25 | $81.2M | $61.7M | ||
| Q1 25 | $80.7M | $78.7M | ||
| Q4 24 | $81.6M | — | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $69.6M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | $322.8M | $594.6M | ||
| Q3 25 | $408.1M | $597.9M | ||
| Q2 25 | $412.2M | $668.7M | ||
| Q1 25 | $418.2M | $1.1B | ||
| Q4 24 | $419.0M | — | ||
| Q3 24 | $424.7M | $134.2M | ||
| Q2 24 | $433.3M | — | ||
| Q1 24 | $462.4M | — |
| Q4 25 | $449.0M | $937.3M | ||
| Q3 25 | $538.2M | $987.4M | ||
| Q2 25 | $553.8M | $1.1B | ||
| Q1 25 | $576.2M | $1.5B | ||
| Q4 24 | $589.3M | — | ||
| Q3 24 | $597.4M | $0 | ||
| Q2 24 | $602.9M | — | ||
| Q1 24 | $648.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $11.8M |
| Free Cash FlowOCF − Capex | $16.1M | $11.6M |
| FCF MarginFCF / Revenue | 6.8% | 8.2% |
| Capex IntensityCapex / Revenue | 0.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $15.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $11.8M | ||
| Q3 25 | $20.1M | $-9.1M | ||
| Q2 25 | $4.2M | $1.5M | ||
| Q1 25 | $5.7M | $12.2M | ||
| Q4 24 | $24.2M | — | ||
| Q3 24 | $7.5M | — | ||
| Q2 24 | $82.4M | — | ||
| Q1 24 | $6.0M | — |
| Q4 25 | $16.1M | $11.6M | ||
| Q3 25 | $17.9M | $-9.3M | ||
| Q2 25 | $2.3M | $1.4M | ||
| Q1 25 | $3.8M | $12.2M | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 6.8% | 8.2% | ||
| Q3 25 | 7.2% | -7.6% | ||
| Q2 25 | 0.8% | 1.2% | ||
| Q1 25 | 1.3% | 11.7% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
TTGT
Segment breakdown not available.
